| 000 | 01715 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513123129.0 | ||
| 264 | 0 | _c19970825 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Deuren, M | |
| 245 | 0 | 0 |
_aThe pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. _h[electronic resource] |
| 260 |
_bBlood _cAug 1997 |
||
| 300 |
_a1101-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 |
_aEndotoxins _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInterleukin 1 Receptor Antagonist Protein |
| 650 | 0 | 4 |
_aInterleukin-1 _xbiosynthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningitis, Meningococcal _xdrug therapy |
| 650 | 0 | 4 |
_aMeningococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Interleukin-1 _xanalysis |
| 650 | 0 | 4 | _aReceptors, Interleukin-1 Type II |
| 650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
| 650 | 0 | 4 |
_aSialoglycoproteins _xbiosynthesis |
| 700 | 1 | _avan der Ven-Jongekrijg, J | |
| 700 | 1 | _aVannier, E | |
| 700 | 1 | _avan Dalen, R | |
| 700 | 1 | _aPesman, G | |
| 700 | 1 | _aBartelink, A K | |
| 700 | 1 | _aDinarello, C A | |
| 700 | 1 | _avan der Meer, J W | |
| 773 | 0 |
_tBlood _gvol. 90 _gno. 3 _gp. 1101-8 |
|
| 999 |
_c9222506 _d9222506 |
||